Internet-Based Cognitive Behavioral Therapy for Depression: A Systematic Review and Individual Patient Data Network Meta-analysis.


Journal

JAMA psychiatry
ISSN: 2168-6238
Titre abrégé: JAMA Psychiatry
Pays: United States
ID NLM: 101589550

Informations de publication

Date de publication:
01 04 2021
Historique:
pubmed: 21 1 2021
medline: 18 1 2022
entrez: 20 1 2021
Statut: ppublish

Résumé

Personalized treatment choices would increase the effectiveness of internet-based cognitive behavioral therapy (iCBT) for depression to the extent that patients differ in interventions that better suit them. To provide personalized estimates of short-term and long-term relative efficacy of guided and unguided iCBT for depression using patient-level information. We searched PubMed, Embase, PsycInfo, and Cochrane Library to identify randomized clinical trials (RCTs) published up to January 1, 2019. Eligible RCTs were those comparing guided or unguided iCBT against each other or against any control intervention in individuals with depression. Available individual patient data (IPD) was collected from all eligible studies. Depression symptom severity was assessed after treatment, 6 months, and 12 months after randomization. We conducted a systematic review and IPD network meta-analysis and estimated relative treatment effect sizes across different patient characteristics through IPD network meta-regression. Patient Health Questionnaire-9 (PHQ-9) scores. Of 42 eligible RCTs, 39 studies comprising 9751 participants with depression contributed IPD to the IPD network meta-analysis, of which 8107 IPD were synthesized. Overall, both guided and unguided iCBT were associated with more effectiveness as measured by PHQ-9 scores than control treatments over the short term and the long term. Guided iCBT was associated with more effectiveness than unguided iCBT (mean difference [MD] in posttreatment PHQ-9 scores, -0.8; 95% CI, -1.4 to -0.2), but we found no evidence of a difference at 6 or 12 months following randomization. Baseline depression was found to be the most important modifier of the relative association for efficacy of guided vs unguided iCBT. Differences between unguided and guided iCBT in people with baseline symptoms of subthreshold depression (PHQ-9 scores 5-9) were small, while guided iCBT was associated with overall better outcomes in patients with baseline PHQ-9 greater than 9. In this network meta-analysis with IPD, guided iCBT was associated with more effectiveness than unguided iCBT for individuals with depression, benefits were more substantial in individuals with moderate to severe depression. Unguided iCBT was associated with similar effectiveness among individuals with symptoms of mild/subthreshold depression. Personalized treatment selection is entirely possible and necessary to ensure the best allocation of treatment resources for depression.

Identifiants

pubmed: 33471111
pii: 2774861
doi: 10.1001/jamapsychiatry.2020.4364
pmc: PMC8027916
doi:

Types de publication

Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

361-371

Subventions

Organisme : NIMH NIH HHS
ID : P50 MH119029
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

Lancet. 2018 Oct 27;392(10157):1553-1598
pubmed: 30314863
Trials. 2016 Aug 03;17(1):387
pubmed: 27488181
J Med Internet Res. 2009 May 11;11(2):e15
pubmed: 19632969
Prev Sci. 2011 Dec;12(4):361-71
pubmed: 21732121
World Psychiatry. 2019 Feb;18(1):20-28
pubmed: 30600624
Behav Res Ther. 2015 Dec;75:20-31
pubmed: 26523885
JAMA Psychiatry. 2019 Jul 1;76(7):700-707
pubmed: 30994877
Psychother Psychosom. 2018;87(1):32-45
pubmed: 29306945
Behav Res Ther. 2010 May;48(5):368-76
pubmed: 20152960
J Consult Clin Psychol. 2012 Oct;80(5):739-749
pubmed: 22663903
Epidemiol Psychiatr Sci. 2017 Feb;26(1):22-36
pubmed: 26810628
PLoS One. 2010 Jun 08;5(6):e10939
pubmed: 20544030
J Med Internet Res. 2016 Mar 07;18(3):e54
pubmed: 26952645
J Consult Clin Psychol. 2017 Apr;85(4):367-380
pubmed: 28230390
JAMA Psychiatry. 2017 Apr 1;74(4):351-359
pubmed: 28241179
World Psychiatry. 2020 Feb;19(1):92-107
pubmed: 31922679
Psychother Psychosom. 2016;85(4):218-28
pubmed: 27230863
BMJ Open. 2019 Jun 5;9(6):e026820
pubmed: 31171550
J Med Internet Res. 2016 Aug 26;18(8):e231
pubmed: 27565118
Res Synth Methods. 2016 Sep;7(3):236-63
pubmed: 26754852
Stat Methods Med Res. 2018 May;27(5):1351-1364
pubmed: 27487843
Br J Psychiatry. 2005 Nov;187:456-61
pubmed: 16260822
Neuropsychiatr Dis Treat. 2017 Mar 31;13:987-1006
pubmed: 28408833
Depress Anxiety. 2017 Mar;34(3):236-245
pubmed: 28009467
Br J Psychiatry. 2004 May;184:386-92
pubmed: 15123501
J Med Internet Res. 2014 May 06;16(5):e121
pubmed: 24800966
Cogn Behav Ther. 2009;38(4):206-21
pubmed: 19221919
Internet Interv. 2017 May 18;9:25-37
pubmed: 30135834
Asian J Psychiatr. 2018 Dec;38:102-107
pubmed: 29146042
Clin Psychol Rev. 2015 Nov;41:16-26
pubmed: 25754289
Lancet Psychiatry. 2020 Jun;7(6):547-560
pubmed: 32304649
J Affect Disord. 2012 Feb;136(3):459-68
pubmed: 22177742
Curr Psychiatry Rep. 2007 Aug;9(4):284-90
pubmed: 17880859
Stat Med. 2013 Dec 30;32(30):5414-29
pubmed: 24123165
Am J Psychiatry. 2019 Apr 1;176(4):315-323
pubmed: 30696270
Internet Interv. 2020 Apr;20:100317
pubmed: 32289019
Br J Psychiatry. 2016 Nov;209(5):414-420
pubmed: 27609813
J Affect Disord. 2019 Jun 1;252:382-393
pubmed: 31003107
Lancet. 2009 Aug 22;374(9690):628-34
pubmed: 19700005
Res Synth Methods. 2012 Jun;3(2):111-25
pubmed: 26062085
Cogn Behav Ther. 2011;40(4):251-66
pubmed: 22060248
J Clin Epidemiol. 2014 Jan;67(1):73-86
pubmed: 24262771
J Med Internet Res. 2008 Nov 20;10(4):e44
pubmed: 19033149
BMJ. 1997 Sep 13;315(7109):629-34
pubmed: 9310563
J Affect Disord. 2018 Oct 1;238:317-326
pubmed: 29902736
Lancet Psychiatry. 2016 May;3(5):415-24
pubmed: 27083119
Eur Neuropsychopharmacol. 2011 Sep;21(9):655-79
pubmed: 21896369
Br J Psychiatry. 2009 Jul;195(1):73-80
pubmed: 19567900
PLoS One. 2012;7(5):e36905
pubmed: 22615841
J Affect Disord. 2017 Oct 15;221:56-64
pubmed: 28628768
BMJ. 2004 Jan 31;328(7434):265
pubmed: 14742346
PLoS One. 2011;6(11):e28099
pubmed: 22140514
Psychol Med. 2007 Dec;37(12):1797-806
pubmed: 17466110
J Clin Epidemiol. 2015 Jan;68(1):52-60
pubmed: 25304503
Behav Ther. 2015 Mar;46(2):193-205
pubmed: 25645168
J Affect Disord. 2015 Jun 1;178:131-41
pubmed: 25805405
Aust N Z J Psychiatry. 2009 Jun;43(6):571-8
pubmed: 19440890
BMJ. 2010 Feb 05;340:c221
pubmed: 20139215
Psychol Med. 2014 Mar;44(4):741-52
pubmed: 23795621
J Affect Disord. 2009 Apr;114(1-3):163-73
pubmed: 18752852
BMJ. 2015 Nov 11;351:h5627
pubmed: 26559241
PLoS One. 2013 Aug 21;8(8):e70086
pubmed: 23990896
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Behav Res Ther. 2012 Aug;50(7-8):513-21
pubmed: 22677231
PLoS One. 2016 Mar 01;11(3):e0149186
pubmed: 26930488
Cogn Behav Ther. 2014;43(4):289-98
pubmed: 24911260
Br J Psychiatry. 2017 May;210(5):362-367
pubmed: 28254959
Behav Res Ther. 2017 Jan;88:19-25
pubmed: 28110672
Behav Ther. 2018 Mar;49(2):295-307
pubmed: 29530267
Clin Psychol Rev. 2018 Jul;63:80-92
pubmed: 29940401
Clin Psychol Psychother. 2013 Jan-Feb;20(1):10-27
pubmed: 21887811

Auteurs

Eirini Karyotaki (E)

Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
Department of Clinical Neuro- and Developmental Psychology, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts.

Orestis Efthimiou (O)

Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
Department of Psychiatry, University of Oxford, Oxford, England.

Clara Miguel (C)

Department of Clinical Neuro- and Developmental Psychology, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
Amsterdam Public Health Research Institute, Amsterdam, the Netherlands.

Frederic Maas Genannt Bermpohl (FMG)

Department of Clinical Psychology and Psychotherapy, University of Wuppertal, Wuppertal, Germany.

Toshi A Furukawa (TA)

Department of Clinical Psychology and Psychotherapy, University of Wuppertal, Wuppertal, Germany.
Department of Health Promotion and Human Behavior, Department of Clinical Epidemiology, Kyoto University Graduate School of Medicine/School of Public Health, Kyoto, Japan.

Pim Cuijpers (P)

Department of Clinical Neuro- and Developmental Psychology, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
Amsterdam Public Health Research Institute, Amsterdam, the Netherlands.

Heleen Riper (H)

Department of Clinical Neuro- and Developmental Psychology, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
Amsterdam Public Health Research Institute, Amsterdam, the Netherlands.
Department of Research and Innovation, GGZ inGeest, Specialized Mental Health Care, Amsterdam, the Netherlands.

Vikram Patel (V)

Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts.

Adriana Mira (A)

PROMOSAM Excellence in Research Program, MINECO, Valencia, Spain.
Department of Personality, Evaluation and Psychological Treatment, Valencia University, Valencia, Spain.

Alan W Gemmil (AW)

Parent-Infant Research Institute, Department of Clinical and Health Psychology, Heidelberg Repatriation Hospital, Austin Health, Ivanhoe, Victoria, Australia.

Albert S Yeung (AS)

Depression Clinical and Research Program, Massachusetts General Hospital, Harvard University, Boston, Massachusetts.

Alfred Lange (A)

Department of Clinical Psychology, University of Amsterdam, Amsterdam, the Netherlands.

Alishia D Williams (AD)

Department of Psychology, University of New South Wales, Sydney, New South Wales, Australia.

Andrew Mackinnon (A)

Prince of Wales Hospital, Black Dog Institute, University of New South Wales, Sydney, New South Wales, Australia.
Center for Mental Health, University of Melbourne, Melbourne, Victoria, Australia.

Anna Geraedts (A)

HumanTotalCare, Utrecht, the Netherlands.

Annemieke van Straten (A)

Department of Clinical Neuro- and Developmental Psychology, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
Amsterdam Public Health Research Institute, Amsterdam, the Netherlands.

Björn Meyer (B)

Research Department, Gaia AG, Hamburg, Germany.
Department of Psychology, City, University of London, London, England.

Cecilia Björkelund (C)

Primary Health Care, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg School of Public Health and Community Medicine, Gothenburg, Sweden.

Christine Knaevelsrud (C)

Department for Clinical Psychological Intervention, Freie Universität Berlin, Berlin, Germany.

Christopher G Beevers (CG)

Department of Psychology and Institute for Mental Health Research, The University of Texas at Austin.

Cristina Botella (C)

Department of Basic Psychology, Clinic and Psychobiology, Jaume I University, Castellon, Spain.
CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto Salud Carlos III, Madrid, Spain.

Daniel R Strunk (DR)

Department of Psychology, The Ohio State University, Columbus, Ohio.

David C Mohr (DC)

Center for Behavioral Intervention Technologies, Department of Preventive Medicine, Northwestern University, Chicago, Illinois.

David D Ebert (DD)

Department of Clinical Psychology and Psychotherapy, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany.

David Kessler (D)

Centre for Academic Primary Care, Bristol Medical School (Population Health Sciences), University of Bristol, Bristol, England.
National Institute for Health Research Bristol Biomedical Research Centre, University Hospitals Bristol NHS Foundation Trust and University of Bristol, Bristol, England.

Derek Richards (D)

E-mental Health Research Group, Trinity College Dublin School of Psychology, Dublin, Ireland.
Clinical Research & Innovation, SilverCloud Health, Dublin, Ireland.

Elizabeth Littlewood (E)

Department of Health Sciences, University of York, York, England.

Erik Forsell (E)

Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet & Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden.

Fan Feng (F)

Benson Henry Institute for Mind Body Medicine, Massachusetts General Hospital, Harvard University, Boston, Massachusetts.

Fang Wang (F)

Department of Psychology and Sleep Medicine, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.

Gerhard Andersson (G)

Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet & Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden.
Department of Behavioral Sciences and Learning, Linköping University, Linköping, Sweden.

Heather Hadjistavropoulos (H)

Department of Psychology, University of Regina, Regina, Saskatchewan, Canada.

Heleen Christensen (H)

Prince of Wales Hospital, Black Dog Institute, University of New South Wales, Sydney, New South Wales, Australia.

Iony D Ezawa (ID)

Department of Psychology, The Ohio State University, Columbus, Ohio.

Isabella Choi (I)

Central Clinical School, Brain and Mind Centre, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.

Isabelle M Rosso (IM)

McLean Hospital, Belmont, Massachusetts.
Harvard Medical School, Boston, Massachusetts.

Jan Philipp Klein (JP)

Department of Psychiatry and Psychotherapy, Luebeck University, Luebeck, Germany.

Jason Shumake (J)

Department of Psychology and Institute for Mental Health Research, The University of Texas at Austin.

Javier Garcia-Campayo (J)

Aragon Institute for Health Research (IIS Aragón), Miguel Servet University Hospital, Zaragoza, Spain.
Primary Care Prevention and Health Promotion Research Network, RedIAPP, Madrid, Spain.

Jeannette Milgrom (J)

Parent-Infant Research Institute, Department of Clinical and Health Psychology, Heidelberg Repatriation Hospital, Austin Health, Ivanhoe, Victoria, Australia.

Jessica Smith (J)

Imperial Clinical Trials Unit, Imperial College London, London, England.

Jesus Montero-Marin (J)

Warneford Hospital, Department of Psychiatry, University of Oxford, Oxford, England.

Jill M Newby (JM)

Department of Psychology, University of New South Wales, Sydney, New South Wales, Australia.
Prince of Wales Hospital, Black Dog Institute, University of New South Wales, Sydney, New South Wales, Australia.

Juana Bretón-López (J)

Department of Basic Psychology, Clinic and Psychobiology, Jaume I University, Castellon, Spain.
CIBER Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto Salud Carlos III, Madrid, Spain.

Justine Schneider (J)

Institute of Mental Health, University of Nottingham, Nottingham, England.

Kristofer Vernmark (K)

Department of Behavioral Sciences and Learning, Linköping University, Linköping, Sweden.
Psykologpartners, Linkoping, Sweden.

Lara Bücker (L)

Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Lisa B Sheeber (LB)

Oregon Research Institute, Eugene, Oregon.

Lisanne Warmerdam (L)

National Health Care Institute, Diemen, the Netherlands.

Louise Farrer (L)

Centre for Mental Health Research, The Australian National University, Canberra, Australia.

Manuel Heinrich (M)

Department for Clinical Psychological Intervention, Freie Universität Berlin, Berlin, Germany.

Marcus J H Huibers (MJH)

Department of Clinical Neuro- and Developmental Psychology, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
Amsterdam Public Health Research Institute, Amsterdam, the Netherlands.

Marie Kivi (M)

Department of Psychology and AgeCap, University of Gothenburg, Gothenburg, Sweden.

Martin Kraepelien (M)

Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet & Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden.

Nicholas R Forand (NR)

Department of Psychiatry and Behavioral Health, The Ohio State University Wexner Medical Center, Columbus, Ohio.
Department of Psychiatry, The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York.

Nicky Pugh (N)

Department of Psychology, University of Regina, Regina, Saskatchewan, Canada.

Nils Lindefors (N)

Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet & Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden.

Ove Lintvedt (O)

Norwegian Center for E-health research, Tromsø, Norway.

Pavle Zagorscak (P)

Department for Clinical Psychological Intervention, Freie Universität Berlin, Berlin, Germany.

Per Carlbring (P)

Department of Psychology, Stockholm University, Stockholm, Sweden.

Rachel Phillips (R)

Faculty of Medicine, Imperial College London School of Public Health, London, England.

Robert Johansson (R)

Department of Psychology, Stockholm University, Stockholm, Sweden.

Ronald C Kessler (RC)

Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts.

Sally Brabyn (S)

Clinical Research & Innovation, SilverCloud Health, Dublin, Ireland.

Sarah Perini (S)

The Clinical Psychology Centre, Sydney, New South Wales, Australia.

Scott L Rauch (SL)

McLean Hospital, Belmont, Massachusetts.

Simon Gilbody (S)

Department of Health Sciences, University of York, York, England.
Hull York Medical School, University of York, York, England.

Steffen Moritz (S)

Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Thomas Berger (T)

Department of Clinical Psychology and Psychotherapy, University of Bern, Bern, Switzerland.

Victor Pop (V)

Department of Clinical and Medical Health Psychology, Tilburg University, Tilburg, the Netherlands.

Viktor Kaldo (V)

Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet & Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden.
Department of Psychology, Faculty of Health and Life Sciences, Linnaeus University, Växjö, Sweden.

Viola Spek (V)

Department of Clinical and Medical Health Psychology, Tilburg University, Tilburg, the Netherlands.

Yvonne Forsell (Y)

Section of Epidemiology and Public Health Intervention Research, Department of Global Public Health, Karolinska Institutet, Stockholm Health Care Services, Region Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH